<p>APOLLO is a proteogenomic study seeking to describe the major genome, transcriptome, proteome and phosphoproteome alterations, subtypes, and molecular predictors of patient outcomes.  This study includes 87 lung adenocarcinomas and matched normal tissues from the Lung Cancer Biospecimen Resource Network (<a href="https://lungbio.sites.virginia.edu/">https://lungbio.sites.virginia.edu/</a>).  Tumor tissues were profiled by whole genome sequencing, transcriptome sequencing, MS-based proteomics and phosphoproteomics, and reverse phase protein arrays.  Matched normal tissues were profiled by whole genome sequencing.  Clinical and sample data include survival times, patient features, and tumor characteristics.</p>

APOLLO1: Proteogenomic Analysis of Lung Adenocarcinoma

Adenocarcinoma of Lung study on CRDC (87 participants)